Clinical, molecular, and immune correlates of the Immunotherapy Response Score in patients with advanced urothelial carcinoma under atezolizumab monotherapy: analysis of the phase II IMvigor210 trial

1. Ferreiro-Pantín, M.
2. Anido-Herranz, U.
3. Betancor, Y.Z.
4. Cebey-López, V.
5. León-Mateos, L.
6. García-González, J.
7. García-Acuña, S.M.
8. Fernández-Díaz, N.
9. Tubio, J.M.C.
10. López-López, R.
11. Ruiz-Bañobre, J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.ESMOOP.2023.101611 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus